Literature DB >> 30661897

Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report.

G Alfano1, P Ventura2, F Fontana3, M Marcacci2, G Ligabue3, S Scarlini2, E Franceschini4, M Codeluppi4, G Guaraldi4, C Mussini4, G Cappelli3.   

Abstract

Rhodococcus equi is a gram-positive coccobacillus responsible for severe infections in patients with weakened immune systems. R equi generally causes pnumonia that may evolve into fatal systemic infection if left untreated. Here, we present a case of a 67-year-old woman affected by acute intermittent porphyria (AIP) who developed R equi pneumonia 7 months after kidney transplantation. Although clinical features at presentation were nonspecific, lung computed tomography showed right perihilar consolidation with a mass-like appearance causing bronchial obstruction. Appropriate antibiotic including intravenous meropenem and oral azithromycin that was then switched to oral levofloxacin and oral azithromycin along with reduction of immunosuppressive therapy resolved pneumonia without provoking an acute attack of porphyria. AIP limited the choice of antibiotics for the treatment of R equi infection because some potentially porphyrinogenic antibacterial agents were avoided. Based on this experience, azithromycin and meropenem can be safely administered for the treatment of R Equi infection in patients with AIP.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30661897     DOI: 10.1016/j.transproceed.2018.02.213

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  1 in total

1.  Combined Liver and Kidney Transplant in Acute Intermittent Porphyria: A Case Report.

Authors:  Gustavo de Sousa Arantes Ferreira; Livia Claudio de Oliveira; Luiz Roberto de Sousa Ulisses; Andre Luis Conde Watanabe; Isabela Novais Medeiros; Helen Souto Siqueira Cardoso; Inara Creão da Costa Alves; Tiago Martins de Almeida; Laura Viana de Lima; Renata Pereira Fontoura; Eduardo Resende Sousa E Silva; Pollyana Lopes de Araújo
Journal:  Am J Case Rep       Date:  2020-11-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.